EICHOR
● Terminated
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
Condition: Generalized Lipodystrophy · Sponsor: Amryt Pharma
About this study
This is an open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and/or hypertriglyceridaemia
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| UZ Leuven | Leuven, Leuven, Belgium | — |
| Hôpital Necker - Enfants Malades | Paris, Paris, France | — |
| Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Universitaire Robert-Debre | Paris, France | — |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg, Free and Hanseatic City of Hamburg, Germany | — |
| Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin | Ulm, Ulm, Germany | — |
| IRCCS Ospedale Pediatrico Bambino Gesù | Chieti, Chieti, Italy | — |
| Azienda Ospedaliera Universitaria "Federico II" | Naples, Naples, Italy | — |
| Azienda Ospedaliero Universitaria Maggiore della Carità di Novara | Novara, Novara, Italy | — |
| Azienda Ospedaliero-Universitaria di Parma | Parma, Parma, Italy | — |
| Azienda Ospedaliero Universitaria Pisana | Pisa, Pisa, Italy | — |
| IRCCS Ospedale Pediatrico Bambino Gesù | Rome, Rome, Italy | — |
| Ospedale Filippo Del Ponte Varese - ASST Sette Laghi | Varese, Varese, Italy | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06502990